Identifying patients with chronic conditions using pharmacy data in Switzerland: an updated mapping approach to the classification of medications

Abstract

BackgroundQuantifying population health is important for public health policy. Since national disease registers recording clinical diagnoses are often not available, pharmacy data were frequently used to identify chronic conditions (CCs) in populations. However, most approaches mapping prescribed drugs to CCs are outdated and unambiguous. The aim of this study was to provide an improved and updated mapping approach to the classification of medications. Furthermore, we aimed to give an overview of the proportions of patients with CCs in Switzerland using this new mapping approach.MethodsThe database included medical and pharmacy claims data (2011) from patients aged 18 years or older. Based on prescription drug data and using the Anatomical Therapeutic Chemical (ATC) classification system, patients with CCs were identified by a medical expert review. Proportions of patients with CCs were calculated by sex and age groups. We constructed multiple logistic regression models to assess the association between patient characteristics and having a CC, as well as between risk factors (diabetes, hyperlipidemia) for cardiovascular diseases (CVD) and CVD as one of the most prevalent CCs.ResultsA total of 22 CCs were identified. In 2011, 62% of the 932′612 subjects enrolled have been prescribed a drug for the treatment of at least one CC. Rheumatologic conditions, CVD and pain were the most frequent CCs. 29% of the persons had CVD, 10% both CVD and hyperlipidemia, 4% CVD and diabetes, and 2% suffered from all of the three conditions. The regression model showed that diabetes and hyperlipidemia were strongly associated with CVD.ConclusionsUsing pharmacy claims data, we developed an updated and improved approach for a feasible and efficient measure of patients’ chronic disease status. Pharmacy drug data may be a valuable source for measuring population’s burden of disease, when clinical data are missing. This approach may contribute to health policy debates about health services sources and risk adjustment modelling.

Comorbidity-adjusted relative survival in newly hospitalized heart failure patients: A population-based study

“…Consistently with previous findings [16], major noncardiac comorbidities exhibited a moderate increase in the hazard for HF death. Notably, the overall performance of the developed relative survival models was similar regardless of which data source was used to ascertain comorbidity and was consistent with published findings [13].…”

“…Renal disease prevalence (14.2%) is slightly underestimated as compared to previous estimates [6,16,17], ranging from 16.1% to 32.3%, probably because DPR was not exploited to infer this comorbidity [13]. Chronic pulmonary disease burden (26.2%) was higher than published estimates [6,16,17], varying between 19% and 20%, since we relied on a broader definition embracing chronic obstructive pulmonary disease and asthma as well.…”

“…The mapping approach proposed by Huber et al [13] for detecting chronic conditions by using pharmacy data, was applied to ATC codes of medicaments dispensed at least twice within 12 months prior to the index admission.…”

Pharmaceutically treated comorbidities and associated healthcare costs among triptan users in Switzerland: A pharmacoepidemiological study from a nationwide health insurance database

“…The following covariables were also included in the study sample and were determined at index date: gender, age in groups, region of residence, type of cost‐sharing (deductibles ranging from 300 to 2500 SFr: low “300 to 500 SFr, high “1000 to 2500 SFr”), type of health plan (basic compulsory insurance model with free choice of provider (standard model) or managed care (MC) model), and patients' co‐morbidity as measured by pharmacy‐based diagnosis groups . The regions of residence included seven major regions of Switzerland and were defined by the Swiss Federal Office of Statistics: Mittelland, Northwest, East, Leman, Ticino, Central, Zurich .…”

Characteristics and health care utilization among patients with chronic heart failure: a longitudinal claim database analysis

“…18 We summed all chronic conditions to establish a drug-based multimorbidity measure. Hospital DRGs (diagnostic related groups, in Dutch: DBCs; refer to hospital payments) in the Netherlands contain specialism and diagnosis codes, and we used these to categorize the claims according to ICD-10 (sub)chapters (e.g.…”